InMed Pharmaceuticals Inc. (MTRI) stock

MTRINasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as INM

Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/30

$18.60+0.25 (+1.36%)

Close on Nov 13, 2026Market cap $102.18MP/E –Yield –

InMed Pharmaceuticals total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

InMed Pharmaceuticals's total debt was $29.31K at Mar 31, 2022.

Change is against the same quarter a year earlier.

Periods

Period	Period end	Value	Change
Q3 FY2022CQ1 2022	Mar 31, 2022	$29.31K	–
Q2 FY2022CQ4 2021	Dec 31, 2021	$58.62K	–

See a number that looks wrong?